Filter
557
Text search:
immune
suppression
Featured
Recommendations
56
New Publications
166
Language
Document type
No document type
379
Guidelines
82
Studies & Reports
66
Manuals
9
Fact sheets
7
Training Material
4
Infographics
4
Situation Updates
3
Strategic & Response Plan
2
Brochures
1
Countries / Regions
India
31
Kenya
28
South Africa
23
Zambia
15
Ethiopia
14
Africa
14
Global
12
Malawi
11
Uganda
10
Tanzania
10
Nigeria
8
Nepal
8
Zimbabwe
7
Myanmar / Burma
7
Bangladesh
6
Western and Central Europe
6
Ghana
5
Cambodia
5
South–East Asia Region
5
Asia
5
Sierra Leone
4
Philippines
4
Namibia
4
Liberia
3
Congo, Democratic Republic of
3
Rwanda
3
Eswatini/ Swaziland
3
Burkina Faso
2
Cameroon
2
Germany
2
Thailand
2
Ukraine
2
Botswana
2
Lesotho
2
East and Southern Africa
2
Latin America and the Carribbean
2
Eastern Europe and Central Asia
2
Georgia
2
Senegal
1
USA
1
Somalia
1
Pakistan
1
China
1
Mozambique
1
Sudan
1
Brazil
1
Madagascar
1
West and Central Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Armenia
1
Southern Africa
1
Russia
1
Estonia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
205
Clinical Guidelines
73
Public Health
23
Women & Child Health
11
Capacity Building
6
Key Resources
4
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
208
TB
40
COVID-19
28
Rapid Response
13
NTDs
12
AMR
9
Mental Health
8
NCDs
7
Refugee
6
Planetary Health
6
Ebola
3
Polio
3
Natural Hazards
3
Pharmacy
3
Zika
2
Specific Hazards
2
Cholera
1
Global Health Education
1
Health Financing Toolbox
1
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re
...
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Expanded IMPACT Program in Zimbabwe
Lea Toto and APHIAplus Nuru ya Bonde programs in Kenya Yekokeb Berhan Program for Highly Vulnerable Children in Ethiopia
Defending Rights
Breaking Barriers
Reaching People with HIV Services
Global Aids Update 2019
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
HIV Treatment
Policy Brief
July 2017
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
Published:December 21, 2018
DOI:https://doi.org/10.1016/S2352-3018(18)30289-3
Assecced: 03.09.2019
Accessed: 29.02.2020
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32